FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Upsher-Smith Laboratories, LLC

Upsher-Smith Laboratories, LLC announced FDA approval of the ANDA for Hydrocodone Bitartrate and Acetaminophen, adding another generic option for this widely used opioid composition. The approval is expected to introduce immediate competition to name-brand products, creating impact on wholesale acquisition costs and pricing in the opioid analgesic market.